

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | apoptotic cell clearance (GO:0043277) | 3.61809550 |
| 2 | cell adhesion mediated by integrin (GO:0033627) | 3.51869470 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.45243454 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.45243454 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.45243454 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 3.45243454 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.45243454 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.45243454 |
| 9 | chondrocyte proliferation (GO:0035988) | 3.44304188 |
| 10 | lymphangiogenesis (GO:0001946) | 3.35025426 |
| 11 | low-density lipoprotein particle clearance (GO:0034383) | 3.27896662 |
| 12 | blood vessel maturation (GO:0001955) | 3.18143266 |
| 13 | regulation of cholesterol storage (GO:0010885) | 3.13087848 |
| 14 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.09423684 |
| 15 | cell migration involved in heart development (GO:0060973) | 2.96870947 |
| 16 | endothelium development (GO:0003158) | 2.96860677 |
| 17 | extracellular matrix assembly (GO:0085029) | 2.93908368 |
| 18 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.88844517 |
| 19 | positive regulation of macrophage cytokine production (GO:0060907) | 2.86796329 |
| 20 | protein localization to endosome (GO:0036010) | 2.86026704 |
| 21 | L-amino acid import (GO:0043092) | 2.79809903 |
| 22 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.77887584 |
| 23 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.74160115 |
| 24 | axon extension involved in axon guidance (GO:0048846) | 2.74002839 |
| 25 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.74002839 |
| 26 | skin morphogenesis (GO:0043589) | 2.69961649 |
| 27 | dermatan sulfate metabolic process (GO:0030205) | 2.68346984 |
| 28 | artery development (GO:0060840) | 2.64756956 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 2.64363348 |
| 30 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.62476782 |
| 31 | alanine transport (GO:0032328) | 2.60082773 |
| 32 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.59478206 |
| 33 | metanephric mesenchyme development (GO:0072075) | 2.58896904 |
| 34 | barbed-end actin filament capping (GO:0051016) | 2.56903345 |
| 35 | lipoprotein transport (GO:0042953) | 2.56595933 |
| 36 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.55572943 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.55132251 |
| 38 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.54105012 |
| 39 | kidney mesenchyme development (GO:0072074) | 2.53781359 |
| 40 | negative regulation of vascular permeability (GO:0043116) | 2.52020466 |
| 41 | paraxial mesoderm development (GO:0048339) | 2.51931961 |
| 42 | sodium ion export (GO:0071436) | 2.51114441 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 2.50075932 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49577161 |
| 45 | semaphorin-plexin signaling pathway (GO:0071526) | 2.49481904 |
| 46 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.48862286 |
| 47 | cell communication by electrical coupling (GO:0010644) | 2.45599403 |
| 48 | stress fiber assembly (GO:0043149) | 2.45193454 |
| 49 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.45008183 |
| 50 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.44771378 |
| 51 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.42779023 |
| 52 | extracellular fibril organization (GO:0043206) | 2.42720955 |
| 53 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.41957180 |
| 54 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.41059378 |
| 55 | basement membrane organization (GO:0071711) | 2.40571585 |
| 56 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.40305882 |
| 57 | amino acid import (GO:0043090) | 2.40293888 |
| 58 | protein heterotrimerization (GO:0070208) | 2.38584396 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 2.38213713 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 2.36853102 |
| 61 | adherens junction assembly (GO:0034333) | 2.36664749 |
| 62 | glomerular basement membrane development (GO:0032836) | 2.36097224 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.35465753 |
| 64 | wound healing, spreading of epidermal cells (GO:0035313) | 2.34970875 |
| 65 | macroautophagy (GO:0016236) | 2.34840277 |
| 66 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.34295167 |
| 67 | smooth muscle tissue development (GO:0048745) | 2.33311566 |
| 68 | regulation of axon guidance (GO:1902667) | 2.33183904 |
| 69 | Notch signaling involved in heart development (GO:0061314) | 2.33136049 |
| 70 | lymph vessel development (GO:0001945) | 2.32996963 |
| 71 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.32646267 |
| 72 | hippo signaling (GO:0035329) | 2.32353592 |
| 73 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.30238838 |
| 74 | phospholipid homeostasis (GO:0055091) | 2.29864754 |
| 75 | endodermal cell differentiation (GO:0035987) | 2.28106177 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.27912831 |
| 77 | endocrine hormone secretion (GO:0060986) | 2.26004921 |
| 78 | regulation of macrophage cytokine production (GO:0010935) | 2.25990960 |
| 79 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.25385203 |
| 80 | negative regulation of fatty acid transport (GO:2000192) | 2.25377178 |
| 81 | cell proliferation involved in metanephros development (GO:0072203) | 2.25136786 |
| 82 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.24928381 |
| 83 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.24739608 |
| 84 | adhesion of symbiont to host cell (GO:0044650) | 2.24479804 |
| 85 | virion attachment to host cell (GO:0019062) | 2.24479804 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.24360114 |
| 87 | cGMP-mediated signaling (GO:0019934) | 2.24084610 |
| 88 | neuron remodeling (GO:0016322) | 2.24006757 |
| 89 | positive regulation of receptor recycling (GO:0001921) | 2.23605446 |
| 90 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.22827396 |
| 91 | I-kappaB phosphorylation (GO:0007252) | 2.22800348 |
| 92 | cellular potassium ion homeostasis (GO:0030007) | 2.20442398 |
| 93 | endocardial cushion development (GO:0003197) | 2.19924432 |
| 94 | axon ensheathment in central nervous system (GO:0032291) | 2.19834545 |
| 95 | central nervous system myelination (GO:0022010) | 2.19834545 |
| 96 | regulation of macrophage chemotaxis (GO:0010758) | 2.19584210 |
| 97 | plasma membrane repair (GO:0001778) | 2.19384270 |
| 98 | cell-substrate adherens junction assembly (GO:0007045) | 2.19246768 |
| 99 | focal adhesion assembly (GO:0048041) | 2.19246768 |
| 100 | peptide cross-linking (GO:0018149) | 2.19128785 |
| 101 | axon extension (GO:0048675) | 2.18997103 |
| 102 | desmosome organization (GO:0002934) | 2.17942510 |
| 103 | glomerular visceral epithelial cell development (GO:0072015) | 2.17423575 |
| 104 | keratinization (GO:0031424) | 2.16485858 |
| 105 | cellular response to cholesterol (GO:0071397) | 2.16415804 |
| 106 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.14551534 |
| 107 | regulation of glomerular filtration (GO:0003093) | 2.13201543 |
| 108 | renal filtration (GO:0097205) | 2.13155357 |
| 109 | chondroitin sulfate catabolic process (GO:0030207) | 2.11305195 |
| 110 | keratan sulfate catabolic process (GO:0042340) | 2.11280150 |
| 111 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.10773258 |
| 112 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.10460568 |
| 113 | astrocyte development (GO:0014002) | 2.10290750 |
| 114 | response to lipoprotein particle (GO:0055094) | 2.10235113 |
| 115 | chondrocyte development (GO:0002063) | 2.10211922 |
| 116 | substrate-dependent cell migration (GO:0006929) | 2.10180677 |
| 117 | extracellular matrix organization (GO:0030198) | 2.09869892 |
| 118 | negative regulation of catenin import into nucleus (GO:0035414) | 2.09750688 |
| 119 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.09620030 |
| 120 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.09335835 |
| 121 | adhesion of symbiont to host (GO:0044406) | 2.09129899 |
| 122 | extracellular structure organization (GO:0043062) | 2.08962596 |
| 123 | positive regulation of fibroblast migration (GO:0010763) | 2.08831592 |
| 124 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.08407101 |
| 125 | protein localization to cell surface (GO:0034394) | 2.08150182 |
| 126 | response to host immune response (GO:0052572) | 2.07075251 |
| 127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.07075251 |
| 128 | collagen metabolic process (GO:0032963) | 2.06549751 |
| 129 | cortical actin cytoskeleton organization (GO:0030866) | 2.06017980 |
| 130 | import into cell (GO:0098657) | 2.04075837 |
| 131 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.03968888 |
| 132 | locomotory exploration behavior (GO:0035641) | 2.03965821 |
| 133 | collagen catabolic process (GO:0030574) | 2.03905390 |
| 134 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.02574094 |
| 135 | positive regulation of fatty acid oxidation (GO:0046321) | 2.02057900 |
| 136 | dermatan sulfate biosynthetic process (GO:0030208) | 2.01907342 |
| 137 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.01320820 |
| 138 | glomerular filtration (GO:0003094) | 2.01200907 |
| 139 | response to fluid shear stress (GO:0034405) | 2.00766641 |
| 140 | regulation of mononuclear cell migration (GO:0071675) | 2.00739729 |
| 141 | collagen fibril organization (GO:0030199) | 2.00642728 |
| 142 | regulation of sequestering of triglyceride (GO:0010889) | 2.00347537 |
| 143 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 1.99779949 |
| 144 | endothelial cell morphogenesis (GO:0001886) | 1.99454412 |
| 145 | regulation of cholesterol homeostasis (GO:2000188) | 1.99411254 |
| 146 | positive regulation of cholesterol efflux (GO:0010875) | 1.96793741 |
| 147 | growth hormone receptor signaling pathway (GO:0060396) | 1.96732949 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 1.96570166 |
| 149 | positive regulation of lipid storage (GO:0010884) | 1.96482651 |
| 150 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.96130510 |
| 151 | glomerular epithelial cell development (GO:0072310) | 1.96087938 |
| 152 | cell migration involved in sprouting angiogenesis (GO:0002042) | 1.95358445 |
| 153 | regulation of integrin activation (GO:0033623) | 1.95355925 |
| 154 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 1.95044406 |
| 155 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.95022329 |
| 156 | response to host (GO:0075136) | 1.95022329 |
| 157 | response to host defenses (GO:0052200) | 1.95022329 |
| 158 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.94491285 |
| 159 | negative regulation of lipid storage (GO:0010888) | 1.94244289 |
| 160 | potassium ion import (GO:0010107) | 1.94079943 |
| 161 | cell-substrate junction assembly (GO:0007044) | 1.93752366 |
| 162 | multicellular organismal metabolic process (GO:0044236) | 1.93695165 |
| 163 | modification by symbiont of host morphology or physiology (GO:0044003) | 1.93122351 |
| 164 | complement activation, alternative pathway (GO:0006957) | 1.92477508 |
| 165 | hemidesmosome assembly (GO:0031581) | 1.92295798 |
| 166 | myelination in peripheral nervous system (GO:0022011) | 1.91722601 |
| 167 | peripheral nervous system axon ensheathment (GO:0032292) | 1.91722601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.92388792 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.47007855 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25771356 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14598512 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91502721 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90758835 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87328572 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83917079 |
| 9 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.81919647 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78854075 |
| 11 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73994747 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70509910 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69642783 |
| 14 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65605195 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61319972 |
| 16 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.59028737 |
| 17 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.57221830 |
| 18 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.56000954 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.47789992 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46156268 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46038681 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44012357 |
| 23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43735976 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43673692 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43672751 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.42644979 |
| 27 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39996810 |
| 28 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38965972 |
| 29 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.38910559 |
| 30 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.38413140 |
| 31 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.38055796 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36385364 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36210693 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35595778 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35595778 |
| 36 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33709868 |
| 37 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33709868 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33032319 |
| 39 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32366709 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.32184014 |
| 41 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31162397 |
| 42 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30181571 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29376606 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28431253 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27595988 |
| 46 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.27576030 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.27121145 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26579932 |
| 49 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25944483 |
| 50 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25564443 |
| 51 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25521044 |
| 52 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25398004 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25124780 |
| 54 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23928079 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23652841 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.23399606 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21886249 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21626763 |
| 59 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.21519207 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21297806 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21228307 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19670696 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19397987 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18935267 |
| 65 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18153308 |
| 66 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17226004 |
| 67 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16878549 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16574890 |
| 69 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16402675 |
| 70 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.16301586 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16060778 |
| 72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15991522 |
| 73 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15821468 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14070018 |
| 75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13636501 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13144295 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12705577 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12274444 |
| 79 | * RXR_22108803_ChIP-Seq_LS180_Human | 1.12239036 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11724432 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11347694 |
| 82 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10146549 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10044700 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08715980 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07714631 |
| 86 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06815671 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06524033 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06352295 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06250688 |
| 90 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05787438 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05635695 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04254861 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02194201 |
| 94 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01673366 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01412358 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00614504 |
| 97 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00317690 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00156411 |
| 99 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99661776 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99395486 |
| 101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99395486 |
| 102 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98735404 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98547136 |
| 104 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98509105 |
| 105 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98273209 |
| 106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97605223 |
| 107 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97432491 |
| 108 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97352568 |
| 109 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97172288 |
| 110 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.96561482 |
| 111 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96153580 |
| 112 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95029357 |
| 113 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94682004 |
| 114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93442116 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93072966 |
| 116 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92901242 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92892568 |
| 118 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91502522 |
| 119 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91399958 |
| 120 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91291553 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91034128 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90460865 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90419438 |
| 124 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89444444 |
| 125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89418992 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89258856 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88757491 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88547828 |
| 129 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88408009 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88289318 |
| 131 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87868451 |
| 132 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86380475 |
| 133 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86004834 |
| 134 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85798775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.96195654 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.96723528 |
| 3 | MP0005275_abnormal_skin_tensile | 2.94937511 |
| 4 | MP0004272_abnormal_basement_membrane | 2.72182667 |
| 5 | MP0001958_emphysema | 2.68659612 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.67573138 |
| 7 | MP0003690_abnormal_glial_cell | 2.66977022 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.66299439 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.52999615 |
| 10 | MP0004858_abnormal_nervous_system | 2.43283830 |
| 11 | MP0003303_peritoneal_inflammation | 2.35981064 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.24898461 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.02793913 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.00880206 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.00151153 |
| 16 | MP0005623_abnormal_meninges_morphology | 1.96960441 |
| 17 | MP0000604_amyloidosis | 1.87318637 |
| 18 | MP0005360_urolithiasis | 1.83099475 |
| 19 | MP0003279_aneurysm | 1.82701391 |
| 20 | MP0004130_abnormal_muscle_cell | 1.81427147 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.78734735 |
| 22 | MP0003045_fibrosis | 1.78734065 |
| 23 | MP0006054_spinal_hemorrhage | 1.76613339 |
| 24 | MP0009840_abnormal_foam_cell | 1.75382097 |
| 25 | MP0003941_abnormal_skin_development | 1.75230926 |
| 26 | MP0003091_abnormal_cell_migration | 1.74884250 |
| 27 | MP0002254_reproductive_system_inflammat | 1.74185741 |
| 28 | MP0003075_altered_response_to | 1.73925724 |
| 29 | MP0004859_abnormal_synaptic_plasticity | 1.68486882 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.68219513 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.47710396 |
| 32 | MP0009278_abnormal_bone_marrow | 1.47329875 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.41258683 |
| 34 | MP0001542_abnormal_bone_strength | 1.41065620 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.36871292 |
| 36 | MP0006138_congestive_heart_failure | 1.35838415 |
| 37 | MP0005409_darkened_coat_color | 1.35635306 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.33172063 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.32427424 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.31700523 |
| 41 | MP0003252_abnormal_bile_duct | 1.30857740 |
| 42 | MP0002295_abnormal_pulmonary_circulatio | 1.30334630 |
| 43 | MP0010329_abnormal_lipoprotein_level | 1.30263470 |
| 44 | MP0000534_abnormal_ureter_morphology | 1.24538688 |
| 45 | MP0000751_myopathy | 1.24523239 |
| 46 | MP0005666_abnormal_adipose_tissue | 1.23725313 |
| 47 | MP0000749_muscle_degeneration | 1.21619685 |
| 48 | MP0002168_other_aberrant_phenotype | 1.21009287 |
| 49 | MP0005083_abnormal_biliary_tract | 1.20443518 |
| 50 | MP0005023_abnormal_wound_healing | 1.19990550 |
| 51 | MP0002796_impaired_skin_barrier | 1.19533429 |
| 52 | MP0004084_abnormal_cardiac_muscle | 1.17452229 |
| 53 | MP0003634_abnormal_glial_cell | 1.17144707 |
| 54 | MP0000920_abnormal_myelination | 1.15792243 |
| 55 | MP0000767_abnormal_smooth_muscle | 1.14668083 |
| 56 | MP0005670_abnormal_white_adipose | 1.14283558 |
| 57 | MP0003283_abnormal_digestive_organ | 1.12857106 |
| 58 | MP0000733_abnormal_muscle_development | 1.12734238 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.12154893 |
| 60 | MP0004270_analgesia | 1.11086307 |
| 61 | MP0004510_myositis | 1.11037962 |
| 62 | MP0009250_abnormal_appendicular_skeleto | 1.10528080 |
| 63 | MP0009384_cardiac_valve_regurgitation | 1.10397077 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.09323908 |
| 65 | MP0003448_altered_tumor_morphology | 1.08079359 |
| 66 | MP0005164_abnormal_response_to | 1.07666445 |
| 67 | MP0005375_adipose_tissue_phenotype | 1.07456045 |
| 68 | MP0003329_amyloid_beta_deposits | 1.05591119 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 1.04558295 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.04144185 |
| 71 | MP0003828_pulmonary_edema | 1.01522387 |
| 72 | MP0002060_abnormal_skin_morphology | 1.01081465 |
| 73 | MP0002108_abnormal_muscle_morphology | 0.99100776 |
| 74 | MP0001299_abnormal_eye_distance/ | 0.98620118 |
| 75 | MP0005171_absent_coat_pigmentation | 0.98598324 |
| 76 | MP0000428_abnormal_craniofacial_morphol | 0.98029921 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.96900957 |
| 78 | MP0003633_abnormal_nervous_system | 0.95644316 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.95575091 |
| 80 | MP0000343_altered_response_to | 0.94833996 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 0.94762268 |
| 82 | MP0005388_respiratory_system_phenotype | 0.92417466 |
| 83 | MP0002133_abnormal_respiratory_system | 0.92417466 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.92370531 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.91683564 |
| 86 | MP0005620_abnormal_muscle_contractility | 0.90828095 |
| 87 | MP0005166_decreased_susceptibility_to | 0.90478665 |
| 88 | MP0005365_abnormal_bile_salt | 0.89767609 |
| 89 | MP0004885_abnormal_endolymph | 0.89489570 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.89433310 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.88333048 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.87470141 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.87453361 |
| 94 | MP0003385_abnormal_body_wall | 0.87449978 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.87005018 |
| 96 | MP0000762_abnormal_tongue_morphology | 0.85858115 |
| 97 | MP0000759_abnormal_skeletal_muscle | 0.83434347 |
| 98 | MP0000747_muscle_weakness | 0.83352725 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.83084355 |
| 100 | MP0003942_abnormal_urinary_system | 0.82760930 |
| 101 | MP0003632_abnormal_nervous_system | 0.81237808 |
| 102 | MP0001177_atelectasis | 0.80042350 |
| 103 | MP0002971_abnormal_brown_adipose | 0.80028621 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.79808234 |
| 105 | MP0008775_abnormal_heart_ventricle | 0.79234432 |
| 106 | MP0005508_abnormal_skeleton_morphology | 0.79092863 |
| 107 | MP0002090_abnormal_vision | 0.78747674 |
| 108 | MP0001915_intracranial_hemorrhage | 0.78587332 |
| 109 | MP0001614_abnormal_blood_vessel | 0.78159362 |
| 110 | MP0002128_abnormal_blood_circulation | 0.77677914 |
| 111 | MP0010678_abnormal_skin_adnexa | 0.77612178 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.77114257 |
| 113 | MP0000249_abnormal_blood_vessel | 0.76445249 |
| 114 | MP0000163_abnormal_cartilage_morphology | 0.75206215 |
| 115 | MP0004087_abnormal_muscle_fiber | 0.75158189 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.74946165 |
| 117 | MP0004883_abnormal_blood_vessel | 0.74932666 |
| 118 | MP0005165_increased_susceptibility_to | 0.74589766 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.73728284 |
| 120 | MP0002115_abnormal_skeleton_extremities | 0.73373551 |
| 121 | MP0010630_abnormal_cardiac_muscle | 0.72606252 |
| 122 | MP0009053_abnormal_anal_canal | 0.72137877 |
| 123 | MP0001849_ear_inflammation | 0.71212947 |
| 124 | MP0000432_abnormal_head_morphology | 0.69802030 |
| 125 | MP0002925_abnormal_cardiovascular_devel | 0.69714793 |
| 126 | MP0003935_abnormal_craniofacial_develop | 0.69541097 |
| 127 | MP0000778_abnormal_nervous_system | 0.69205967 |
| 128 | MP0003631_nervous_system_phenotype | 0.68950309 |
| 129 | MP0006082_CNS_inflammation | 0.68713421 |
| 130 | MP0005085_abnormal_gallbladder_physiolo | 0.68414171 |
| 131 | MP0005332_abnormal_amino_acid | 0.68153944 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.68006652 |
| 133 | MP0002972_abnormal_cardiac_muscle | 0.65431815 |
| 134 | MP0000049_abnormal_middle_ear | 0.63590546 |
| 135 | MP0005369_muscle_phenotype | 0.63543009 |
| 136 | MP0000462_abnormal_digestive_system | 0.63153396 |
| 137 | MP0003136_yellow_coat_color | 0.62306254 |
| 138 | MP0001243_abnormal_dermal_layer | 0.60451053 |
| 139 | MP0003755_abnormal_palate_morphology | 0.60250541 |
| 140 | MP0000579_abnormal_nail_morphology | 0.59015221 |
| 141 | MP0000467_abnormal_esophagus_morphology | 0.58949190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 3.82786626 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.77636933 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.60919071 |
| 4 | Broad metatarsal (HP:0001783) | 3.42577214 |
| 5 | Shallow orbits (HP:0000586) | 3.18387996 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 3.11914008 |
| 7 | Myocardial infarction (HP:0001658) | 3.02709009 |
| 8 | Turricephaly (HP:0000262) | 2.98728230 |
| 9 | Wormian bones (HP:0002645) | 2.93624277 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 2.89529839 |
| 11 | Neonatal short-limb short stature (HP:0008921) | 2.86955370 |
| 12 | Axonal loss (HP:0003447) | 2.66765593 |
| 13 | Mitral valve prolapse (HP:0001634) | 2.66316308 |
| 14 | Ankle contracture (HP:0006466) | 2.58887494 |
| 15 | Aortic dissection (HP:0002647) | 2.58771827 |
| 16 | Atrophic scars (HP:0001075) | 2.56976786 |
| 17 | Complement deficiency (HP:0004431) | 2.55518941 |
| 18 | Peritonitis (HP:0002586) | 2.55153111 |
| 19 | Hematochezia (HP:0002573) | 2.53398366 |
| 20 | Neurofibrillary tangles (HP:0002185) | 2.53258948 |
| 21 | Deep venous thrombosis (HP:0002625) | 2.44126650 |
| 22 | Increased connective tissue (HP:0009025) | 2.43599887 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.36783651 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.36233902 |
| 25 | Wide anterior fontanel (HP:0000260) | 2.35693478 |
| 26 | Xanthomatosis (HP:0000991) | 2.35076909 |
| 27 | Bladder diverticulum (HP:0000015) | 2.32434499 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.31982277 |
| 29 | Abnormality of dentin (HP:0010299) | 2.29360789 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25816429 |
| 31 | Genu recurvatum (HP:0002816) | 2.25731377 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.21696164 |
| 33 | Aortic aneurysm (HP:0004942) | 2.21494297 |
| 34 | Limited hip movement (HP:0008800) | 2.20255077 |
| 35 | Muscle fiber splitting (HP:0003555) | 2.20097485 |
| 36 | Dilatation of the ascending aorta (HP:0005111) | 2.18846059 |
| 37 | Increased CSF protein (HP:0002922) | 2.18605941 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17970976 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.17970976 |
| 40 | Action tremor (HP:0002345) | 2.14661892 |
| 41 | Aneurysm (HP:0002617) | 2.14354835 |
| 42 | Fragile skin (HP:0001030) | 2.13298495 |
| 43 | Skin nodule (HP:0200036) | 2.12109340 |
| 44 | Mitral regurgitation (HP:0001653) | 2.11984892 |
| 45 | Esophageal varix (HP:0002040) | 2.11883464 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 2.11494443 |
| 47 | Ulnar bowing (HP:0003031) | 2.09853368 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09656163 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09656163 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09656163 |
| 51 | Amyloidosis (HP:0011034) | 2.09606168 |
| 52 | Abnormality of complement system (HP:0005339) | 2.08172308 |
| 53 | Thick nail (HP:0001805) | 2.07320245 |
| 54 | Supranuclear gaze palsy (HP:0000605) | 2.06895810 |
| 55 | Joint laxity (HP:0001388) | 2.06420630 |
| 56 | Hemiplegia (HP:0002301) | 2.01146414 |
| 57 | Aplasia involving bones of the extremities (HP:0009825) | 2.00325818 |
| 58 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00325818 |
| 59 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00325818 |
| 60 | Vertebral compression fractures (HP:0002953) | 1.99939088 |
| 61 | Striae distensae (HP:0001065) | 1.99726117 |
| 62 | Peripheral demyelination (HP:0011096) | 1.99430148 |
| 63 | Alopecia of scalp (HP:0002293) | 1.99410053 |
| 64 | Hyperextensible skin (HP:0000974) | 1.99342552 |
| 65 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97729201 |
| 66 | Osteolytic defects of the hand bones (HP:0009699) | 1.97729201 |
| 67 | Bowel diverticulosis (HP:0005222) | 1.95739355 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.95399694 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95050517 |
| 70 | Spondylolisthesis (HP:0003302) | 1.94897422 |
| 71 | Aortic regurgitation (HP:0001659) | 1.94859302 |
| 72 | Mitral stenosis (HP:0001718) | 1.94608449 |
| 73 | Pulmonary artery stenosis (HP:0004415) | 1.94313194 |
| 74 | Nephritis (HP:0000123) | 1.92184169 |
| 75 | Bronchomalacia (HP:0002780) | 1.91392779 |
| 76 | Mild short stature (HP:0003502) | 1.91366744 |
| 77 | Vascular tortuosity (HP:0004948) | 1.90123043 |
| 78 | Blue sclerae (HP:0000592) | 1.90056989 |
| 79 | Aortic valve stenosis (HP:0001650) | 1.89628332 |
| 80 | Arterial tortuosity (HP:0005116) | 1.87859391 |
| 81 | Upper limb amyotrophy (HP:0009129) | 1.85821192 |
| 82 | Distal upper limb amyotrophy (HP:0007149) | 1.85821192 |
| 83 | Slender build (HP:0001533) | 1.85368917 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 1.83709116 |
| 85 | Vertebral arch anomaly (HP:0008438) | 1.83478787 |
| 86 | Glomerulonephritis (HP:0000099) | 1.82525923 |
| 87 | Broad ribs (HP:0000885) | 1.81605473 |
| 88 | Cervical subluxation (HP:0003308) | 1.81500069 |
| 89 | Lymphangioma (HP:0100764) | 1.81302638 |
| 90 | Hip contracture (HP:0003273) | 1.81121116 |
| 91 | Ectopia lentis (HP:0001083) | 1.80771296 |
| 92 | Achilles tendon contracture (HP:0001771) | 1.80629881 |
| 93 | Coronal craniosynostosis (HP:0004440) | 1.79460251 |
| 94 | Soft skin (HP:0000977) | 1.79384892 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 1.78404034 |
| 96 | Hydroxyprolinuria (HP:0003080) | 1.78404034 |
| 97 | Hypoplastic ischia (HP:0003175) | 1.78010009 |
| 98 | Disproportionate tall stature (HP:0001519) | 1.77938646 |
| 99 | Hypercholesterolemia (HP:0003124) | 1.77528853 |
| 100 | Follicular hyperkeratosis (HP:0007502) | 1.77266411 |
| 101 | Overgrowth (HP:0001548) | 1.77118328 |
| 102 | Difficulty running (HP:0009046) | 1.75159018 |
| 103 | Macroorchidism (HP:0000053) | 1.75081287 |
| 104 | Knee flexion contracture (HP:0006380) | 1.74083535 |
| 105 | Hammertoe (HP:0001765) | 1.73290763 |
| 106 | Camptodactyly of toe (HP:0001836) | 1.72788374 |
| 107 | Epidermoid cyst (HP:0200040) | 1.71835660 |
| 108 | Hypoventilation (HP:0002791) | 1.71247162 |
| 109 | Wrist flexion contracture (HP:0001239) | 1.70981704 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.69367612 |
| 111 | Focal segmental glomerulosclerosis (HP:0000097) | 1.69107186 |
| 112 | Round ear (HP:0100830) | 1.68979990 |
| 113 | Thin bony cortex (HP:0002753) | 1.68457947 |
| 114 | Abnormality of the acetabulum (HP:0003170) | 1.67391999 |
| 115 | Scapular winging (HP:0003691) | 1.66259608 |
| 116 | Hyperlipoproteinemia (HP:0010980) | 1.64455636 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.64397984 |
| 118 | Natal tooth (HP:0000695) | 1.64261404 |
| 119 | Biconcave vertebral bodies (HP:0004586) | 1.63889996 |
| 120 | Short nail (HP:0001799) | 1.63824866 |
| 121 | Hypoplasia of the iris (HP:0007676) | 1.62442874 |
| 122 | Abnormality of the ischium (HP:0003174) | 1.62307786 |
| 123 | Tetraparesis (HP:0002273) | 1.62264450 |
| 124 | Disinhibition (HP:0000734) | 1.62091890 |
| 125 | Spinal rigidity (HP:0003306) | 1.61736515 |
| 126 | Loss of speech (HP:0002371) | 1.61703249 |
| 127 | Infantile muscular hypotonia (HP:0008947) | 1.61535608 |
| 128 | Osteoarthritis (HP:0002758) | 1.60357300 |
| 129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.59762019 |
| 130 | Abnormality of the periventricular white matter (HP:0002518) | 1.59270279 |
| 131 | Hyporeflexia of lower limbs (HP:0002600) | 1.59206995 |
| 132 | Global brain atrophy (HP:0002283) | 1.58475129 |
| 133 | Lower limb amyotrophy (HP:0007210) | 1.58470368 |
| 134 | Tibial bowing (HP:0002982) | 1.57645890 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 1.57480560 |
| 136 | Hemorrhage of the eye (HP:0011885) | 1.56864626 |
| 137 | Elbow flexion contracture (HP:0002987) | 1.56338727 |
| 138 | Venous abnormality (HP:0002624) | 1.55688449 |
| 139 | Urethral obstruction (HP:0000796) | 1.55066866 |
| 140 | Venous insufficiency (HP:0005293) | 1.54756330 |
| 141 | Spinal cord compression (HP:0002176) | 1.53805094 |
| 142 | Protruding ear (HP:0000411) | 1.52020894 |
| 143 | Bell-shaped thorax (HP:0001591) | 1.51449094 |
| 144 | Arnold-Chiari malformation (HP:0002308) | 1.49345833 |
| 145 | Coxa vara (HP:0002812) | 1.48070055 |
| 146 | Cardiovascular calcification (HP:0011915) | 1.47813714 |
| 147 | Pulmonic stenosis (HP:0001642) | 1.47181040 |
| 148 | Abnormal delivery (HP:0001787) | 1.45603833 |
| 149 | Broad long bones (HP:0005622) | 1.45257984 |
| 150 | Bradycardia (HP:0001662) | 1.44947763 |
| 151 | Laryngomalacia (HP:0001601) | 1.42429939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.05147357 |
| 2 | RIPK1 | 2.93004846 |
| 3 | DDR2 | 2.70057475 |
| 4 | CAMK1D | 2.67047657 |
| 5 | CAMK1G | 2.42903341 |
| 6 | PDGFRA | 2.30913243 |
| 7 | MYLK | 2.20013768 |
| 8 | SIK1 | 2.05981889 |
| 9 | AKT3 | 2.03456108 |
| 10 | ERN1 | 2.01892624 |
| 11 | LATS1 | 1.97579730 |
| 12 | TTN | 1.95667841 |
| 13 | MARK1 | 1.95145893 |
| 14 | BMX | 1.90640633 |
| 15 | EPHB1 | 1.74355962 |
| 16 | DMPK | 1.66987509 |
| 17 | PTK6 | 1.66631794 |
| 18 | PKN2 | 1.61982271 |
| 19 | TYRO3 | 1.60581821 |
| 20 | MAP3K9 | 1.55381693 |
| 21 | NTRK1 | 1.53393196 |
| 22 | PRKD3 | 1.52806413 |
| 23 | TGFBR2 | 1.49234911 |
| 24 | KSR2 | 1.47558451 |
| 25 | DAPK2 | 1.36830715 |
| 26 | PAK6 | 1.36284934 |
| 27 | LATS2 | 1.31832685 |
| 28 | FGR | 1.31173298 |
| 29 | PDGFRB | 1.29217261 |
| 30 | EEF2K | 1.27327874 |
| 31 | ICK | 1.25977231 |
| 32 | STK38L | 1.24589616 |
| 33 | LMTK2 | 1.21433350 |
| 34 | JAK1 | 1.19919558 |
| 35 | FGFR2 | 1.18140228 |
| 36 | FER | 1.14855754 |
| 37 | STK38 | 1.13634340 |
| 38 | MAPK7 | 1.12639263 |
| 39 | MAP3K13 | 1.11747070 |
| 40 | RIPK4 | 1.10737992 |
| 41 | CAMKK1 | 1.10653599 |
| 42 | PTK2 | 1.09712981 |
| 43 | CSK | 1.05873288 |
| 44 | PRKCH | 1.05648292 |
| 45 | FES | 1.04978937 |
| 46 | MAP3K2 | 1.03138768 |
| 47 | CDK12 | 1.02942685 |
| 48 | TRPM7 | 1.01748933 |
| 49 | MET | 1.00345993 |
| 50 | RET | 0.98536889 |
| 51 | SGK3 | 0.98091202 |
| 52 | ROCK2 | 0.94872118 |
| 53 | FGFR4 | 0.94747211 |
| 54 | FGFR3 | 0.94499814 |
| 55 | PTK2B | 0.93395421 |
| 56 | STK24 | 0.92914195 |
| 57 | PNCK | 0.92754774 |
| 58 | EPHA4 | 0.90460882 |
| 59 | TIE1 | 0.90119236 |
| 60 | CDK6 | 0.90108563 |
| 61 | MAPK12 | 0.89712437 |
| 62 | ERBB2 | 0.84060312 |
| 63 | ERBB4 | 0.79750010 |
| 64 | MAP3K6 | 0.79170394 |
| 65 | MTOR | 0.78396933 |
| 66 | TGFBR1 | 0.78043414 |
| 67 | PRKD1 | 0.77923100 |
| 68 | ABL2 | 0.76977486 |
| 69 | PHKG1 | 0.76263564 |
| 70 | PHKG2 | 0.76263564 |
| 71 | TBK1 | 0.76028540 |
| 72 | CASK | 0.75664522 |
| 73 | WNK1 | 0.75460593 |
| 74 | EPHB2 | 0.75394793 |
| 75 | ALK | 0.74261815 |
| 76 | TYK2 | 0.73997652 |
| 77 | NTRK3 | 0.73616488 |
| 78 | JAK2 | 0.72800982 |
| 79 | CAMK2B | 0.72173879 |
| 80 | GSK3A | 0.71824964 |
| 81 | PDPK1 | 0.71115656 |
| 82 | KIT | 0.70998136 |
| 83 | PAK2 | 0.69549604 |
| 84 | NTRK2 | 0.69192849 |
| 85 | EGFR | 0.68621598 |
| 86 | PRKAA2 | 0.68168669 |
| 87 | SCYL2 | 0.67635528 |
| 88 | CAMK1 | 0.67322945 |
| 89 | TAOK1 | 0.66927005 |
| 90 | SIK2 | 0.66506394 |
| 91 | RPS6KA2 | 0.66041354 |
| 92 | PKN1 | 0.65552366 |
| 93 | CAMK2G | 0.63015837 |
| 94 | FYN | 0.62429813 |
| 95 | PAK3 | 0.60981150 |
| 96 | STK39 | 0.60903273 |
| 97 | SRC | 0.60215976 |
| 98 | MAP3K7 | 0.59901050 |
| 99 | LIMK1 | 0.59767075 |
| 100 | STK3 | 0.59283857 |
| 101 | MOS | 0.57209451 |
| 102 | ROCK1 | 0.56895967 |
| 103 | KDR | 0.56684554 |
| 104 | EPHA3 | 0.56680207 |
| 105 | MST1R | 0.55714763 |
| 106 | MAP2K1 | 0.55410714 |
| 107 | SGK1 | 0.54385850 |
| 108 | PAK4 | 0.54139788 |
| 109 | HCK | 0.53627404 |
| 110 | MATK | 0.52987284 |
| 111 | NEK9 | 0.52829051 |
| 112 | INSR | 0.52051163 |
| 113 | TNIK | 0.51682004 |
| 114 | MAP3K1 | 0.51487104 |
| 115 | CDC42BPA | 0.51216828 |
| 116 | PRKCE | 0.50823697 |
| 117 | MAPK10 | 0.50518123 |
| 118 | FGFR1 | 0.50472353 |
| 119 | CDK5 | 0.50314313 |
| 120 | ABL1 | 0.49506543 |
| 121 | PRKG2 | 0.49217064 |
| 122 | SGK223 | 0.49127514 |
| 123 | SGK494 | 0.49127514 |
| 124 | PRKD2 | 0.48993492 |
| 125 | PLK2 | 0.48892029 |
| 126 | MAP2K4 | 0.47777810 |
| 127 | CAMK2D | 0.46541693 |
| 128 | SGK2 | 0.45940509 |
| 129 | GRK5 | 0.45558223 |
| 130 | CAMK4 | 0.45357566 |
| 131 | MARK2 | 0.43343719 |
| 132 | PDK1 | 0.42757040 |
| 133 | CAMK2A | 0.39922650 |
| 134 | UHMK1 | 0.37794399 |
| 135 | MAPK4 | 0.37553288 |
| 136 | MAPKAPK5 | 0.37281806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.39195672 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79069198 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71827344 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69124434 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.53543406 |
| 6 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44846368 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44463651 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42316988 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41154554 |
| 10 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.36199995 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.36003577 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35667024 |
| 13 | Melanogenesis_Homo sapiens_hsa04916 | 1.27526374 |
| 14 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.27520119 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.27100562 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.25975291 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24865561 |
| 18 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.24474685 |
| 19 | Amoebiasis_Homo sapiens_hsa05146 | 1.22159029 |
| 20 | Tight junction_Homo sapiens_hsa04530 | 1.20773350 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.18960288 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18856453 |
| 23 | Long-term potentiation_Homo sapiens_hsa04720 | 1.17587823 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16856784 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16024910 |
| 26 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16010718 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11462991 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09111355 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06105171 |
| 30 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.05483648 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03928335 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02965514 |
| 33 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.01888838 |
| 34 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01666809 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00228023 |
| 36 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99955878 |
| 37 | Malaria_Homo sapiens_hsa05144 | 0.99634904 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99202810 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98452305 |
| 40 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97033359 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96660672 |
| 42 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.96362106 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 0.95742851 |
| 44 | Adherens junction_Homo sapiens_hsa04520 | 0.94624340 |
| 45 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.94379596 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93999616 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.92586912 |
| 48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92529705 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91505052 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87643856 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86571832 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86519672 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85951503 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.85587618 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83939552 |
| 56 | Pathways in cancer_Homo sapiens_hsa05200 | 0.83530634 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83356158 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81898427 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81503422 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80884519 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79536126 |
| 62 | Long-term depression_Homo sapiens_hsa04730 | 0.79466564 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79463441 |
| 64 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78684099 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78563016 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78526324 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78382089 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.78251021 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77950474 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77835424 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.77529746 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77433267 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.76936751 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75582436 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75355553 |
| 76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73849492 |
| 77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.73527616 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73520824 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73430302 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72565292 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69498324 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69314296 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68795247 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.68018811 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67878623 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.67866674 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67720966 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67604670 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.67286843 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66216616 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.64549510 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63507065 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.62955813 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.62386309 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62381647 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62355669 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61961166 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61358795 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61257548 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.60427850 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60418966 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60318751 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.59811232 |
| 104 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58786910 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58665491 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58115448 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.58096622 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57998621 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57692824 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57138592 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.57124504 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.57068221 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56958206 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.56558083 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56346552 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55957901 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55812906 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55726785 |
| 119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55157893 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53740516 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53714628 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53552553 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53161356 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.52562085 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52198773 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.52150003 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.51807507 |
| 128 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51214068 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51055111 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50452244 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50109187 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.49107571 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48972202 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48082929 |
| 135 | ABC transporters_Homo sapiens_hsa02010 | 0.47842467 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47702668 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47331078 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47072206 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47062240 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46788268 |

